Rapid microalbuminuria screening in type 2 diabetes mellitus: Simlified approach with Micral test strips and specific gravity

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1881-1885

  Parikh, Chirag R ^a   Fischer, Michael J ^a   Estacio, Raymond ^b   Schier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Micral test; Screening test; Sensitivity; Specific gravity

Indexed keywords

ALBUMIN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELATIVE DENSITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURBIDIMETRY; URINALYSIS;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAGENT STRIPS; SPECIFIC GRAVITY; TIME FACTORS;

EID: 3242716688     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh300     Document Type: Article

References (20)

1. Amos AF, McCarthy DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 [Suppl 5]: S1-S85
2. Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459
3. Berrut G, Bouhanick B, Fabbri P et al. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Clin Nephrol 1997; 48: 92-97
4. Savage S, Estacio RO, Jeffers BW, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996; 19: 1243-1248
5. Bennett PH, Haffner S, Kasiske BL et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107-112
6. Kraft SK, Lazaridis EN, Qiu C, Clark CM, Jr, Marrero DG. Screening and treatment of diabetic nephropathy by primary care physicians. J Gen Intern Med 1999; 14: 88-97
7. Mainous AG, III, Gill JM. The lack of screening for diabetic nephropathy: evidence from a privately insured population. Fam Med 2001; 33: 115-119
8. Mogensen CE, Viberti GC, Peheim E et al. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997; 20: 1642-1646
9. Fernandez Fernandez I, Paez Pinto JM, Hermosin Bono T et al. Rapid screening test evaluation for microalbuminuria in diabetes mellitus. Acta Diabetol 1998; 35: 199-202
10. Parikh CR, Gyamlani GG, Carvounis CP. Screening for microalbuminuria simplified by urine specific gravity. Am J Nephrol 2002; 22: 315-319
11. Estacio RO, Savage S, Nagel NJ, Schrier RW. Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes Trial. Controlled Clinical Trials 1996; 17: 242-257
12. Tighe P. Laboratory-based quality assurance programme for near-patient urine dipstick testing, 1990-1997: development, cmanagement and results. Br J Biomed Sci 1999; 56: 6-15
13. Minetti EE, Cozzi MG, Granata S, Guidi E. Accuracy of the urinary albumin titrator stick 'Micral Test' in kidney-disease patients. Nephrol Dial Transplant 1997; 12: 78-80
14. Estacio R, Schrier RW. Pathogenesis and treatment of hypertension in the diabetic patient. In: Schrier RW, ed. Diseases of the Kidney and Urinary, Tract, 7th edn. Lippincott Williams and Wilkins, pp. 1489-1500, 2001
15. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259
16. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford NJ, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-652
17. Schrier RW, Estacio RO, Esler A, Mehler PS. Effects of aggressive blood pressure control normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61: 1086-1096
18. Turner R, Holma R, Stratton I et al. for the UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998; 317: 703-713
19. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P for the Irbesartan in Patients with type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with Type 2 diabetes. N Engl J Med 2001; 345: 870-878
20. Brenner BM, Cooper ME, deZeeuw D et al. for the RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869